Bollard Group’s Autolus Therapeutics AUTL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q3
Sell
-3,276
Closed -$53K 440
2020
Q2
$53K Buy
+3,276
New +$53K ﹤0.01% 338